SABBY MANAGEMENT, LLC - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 73 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2016. The put-call ratio across all filers is 1.19 and the average weighting 0.5%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q4 2016$3,698,000
+28.5%
210,978
+74.4%
0.22%
+99.1%
Q3 2016$2,878,000
-12.7%
120,964
-41.3%
0.11%
-37.2%
Q2 2016$3,298,000
+40.6%
206,131
+83.7%
0.17%
+47.0%
Q1 2016$2,346,000
+33.4%
112,184
+72.2%
0.12%
+20.6%
Q4 2015$1,759,000
-25.5%
65,158
-23.4%
0.10%0.0%
Q3 2015$2,362,00085,0110.10%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q2 2016
NameSharesValueWeighting ↓
TANG KEVIN 240,000$1,116,00099.38%
TANG CAPITAL MANAGEMENT LLC 9,607,934$44,677,0008.98%
HealthInvest Partners AB 830,000$3,860,0005.44%
RTW INVESTMENTS, LP 2,327,903$10,825,0000.16%
GLOBEFLEX CAPITAL L P 185,598$864,0000.09%
WealthTrust Axiom LLC 25,400$118,0000.04%
HOLLENCREST CAPITAL MANAGEMENT 82,355$383,0000.03%
FIRST MIDWEST BANK TRUST DIVISION 41,731$194,0000.02%
ACADIAN ASSET MANAGEMENT LLC 435,387$2,023,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 17,176$80,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders